Rotavirus disease burden pre-vaccine introduction in young children in Rural Southern Mozambique, an area of high HIV prevalence.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
29
07
2020
accepted:
23
03
2021
entrez:
8
4
2021
pubmed:
9
4
2021
medline:
18
9
2021
Statut:
epublish
Résumé
Rotavirus vaccines have been adopted in African countries since 2009, including Mozambique (2015). Disease burden data are needed to evaluate the impact of rotavirus vaccine. We report the burden of rotavirus-associated diarrhea in Mozambique from the Global Enteric Multicenter Study (GEMS) before vaccine introduction. A case-control study (GEMS), was conducted in Manhiça district, recruiting children aged 0-59 months with moderate-to-severe diarrhea (MSD) and less-severe-diarrhea (LSD) between December 2007 and November 2012; including 1-3 matched (age, sex and neighborhood) healthy community controls. Clinical and epidemiological data and stool samples (for laboratory investigation) were collected. Association of rotavirus with MSD or LSD was determined by conditional logistic regression and adjusted attributable fractions (AF) calculated, and risk factors for rotavirus diarrhea assessed. Overall 915 cases and 1,977 controls for MSD, and 431 cases and 430 controls for LSD were enrolled. Rotavirus positivity was 44% (217/495) for cases and 15% (160/1046) of controls, with AF = 34.9% (95% CI: 32.85-37.06) and adjusted Odds Ratio (aOR) of 6.4 p< 0.0001 in infants with MSD compared to 30% (46/155) in cases and 14% (22/154) in controls yielding AF = 18.7%, (95% CI: 12.02-25.39) and aOR = 2.8, p = 0.0011 in infants with LSD. The proportion of children with rotavirus was 32% (21/66) among HIV-positive children and 23% (128/566) among HIV-negative ones for MSD. Presence of animals in the compound (OR = 1.9; p = 0.0151) and giving stored water to the child (OR = 2.0, p = 0.0483) were risk factors for MSD; while animals in the compound (OR = 2.37, p = 0.007); not having routine access to water on a daily basis (OR = 1.53, p = 0.015) and washing hands before cooking (OR = 1.76, p = 0.0197) were risk factors for LSD. The implementation of vaccination against rotavirus may likely result in a significant reduction of rotavirus-associated diarrhea, suggesting the need for monitoring of vaccine impact.
Sections du résumé
BACKGROUND
Rotavirus vaccines have been adopted in African countries since 2009, including Mozambique (2015). Disease burden data are needed to evaluate the impact of rotavirus vaccine. We report the burden of rotavirus-associated diarrhea in Mozambique from the Global Enteric Multicenter Study (GEMS) before vaccine introduction.
METHODS
A case-control study (GEMS), was conducted in Manhiça district, recruiting children aged 0-59 months with moderate-to-severe diarrhea (MSD) and less-severe-diarrhea (LSD) between December 2007 and November 2012; including 1-3 matched (age, sex and neighborhood) healthy community controls. Clinical and epidemiological data and stool samples (for laboratory investigation) were collected. Association of rotavirus with MSD or LSD was determined by conditional logistic regression and adjusted attributable fractions (AF) calculated, and risk factors for rotavirus diarrhea assessed.
RESULTS
Overall 915 cases and 1,977 controls for MSD, and 431 cases and 430 controls for LSD were enrolled. Rotavirus positivity was 44% (217/495) for cases and 15% (160/1046) of controls, with AF = 34.9% (95% CI: 32.85-37.06) and adjusted Odds Ratio (aOR) of 6.4 p< 0.0001 in infants with MSD compared to 30% (46/155) in cases and 14% (22/154) in controls yielding AF = 18.7%, (95% CI: 12.02-25.39) and aOR = 2.8, p = 0.0011 in infants with LSD. The proportion of children with rotavirus was 32% (21/66) among HIV-positive children and 23% (128/566) among HIV-negative ones for MSD. Presence of animals in the compound (OR = 1.9; p = 0.0151) and giving stored water to the child (OR = 2.0, p = 0.0483) were risk factors for MSD; while animals in the compound (OR = 2.37, p = 0.007); not having routine access to water on a daily basis (OR = 1.53, p = 0.015) and washing hands before cooking (OR = 1.76, p = 0.0197) were risk factors for LSD.
CONCLUSION
The implementation of vaccination against rotavirus may likely result in a significant reduction of rotavirus-associated diarrhea, suggesting the need for monitoring of vaccine impact.
Identifiants
pubmed: 33831068
doi: 10.1371/journal.pone.0249714
pii: PONE-D-20-23687
pmc: PMC8031087
doi:
Substances chimiques
Rotavirus Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0249714Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Déclaration de conflit d'intérêts
The authors have no conflict of interest
Références
Vaccine. 2018 Nov 12;36(47):7205-7209
pubmed: 29128381
Lancet. 2010 Aug 21;376(9741):615-23
pubmed: 20692031
S Afr Med J. 2009 Apr;99(4):249-52
pubmed: 19588778
Am J Trop Med Hyg. 2013 Jul;89(1 Suppl):41-48
pubmed: 23629927
PLoS One. 2014 Jun 26;9(6):e100953
pubmed: 24968018
Clin Infect Dis. 2012 Dec;55 Suppl 4:S232-45
pubmed: 23169936
Avian Dis. 2014 Mar;58(1):153-7
pubmed: 24758129
Vaccine. 2017 Mar 23;35(13):1663-1667
pubmed: 28242070
Clin Infect Dis. 2012 Dec;55 Suppl 4:S294-302
pubmed: 23169941
Lancet Glob Health. 2019 May;7(5):e568-e584
pubmed: 31000128
Infect Genet Evol. 2014 Oct;27:156-62
pubmed: 25075468
Lancet. 2010 Aug 21;376(9741):606-14
pubmed: 20692030
Int J Infect Dis. 2018 Aug;73:10-17
pubmed: 29852260
Vaccine. 2018 Nov 12;36(47):7119-7123
pubmed: 29914848
Int J Epidemiol. 2013 Oct;42(5):1309-18
pubmed: 24159076
PLoS One. 2015 Jul 06;10(7):e0132053
pubmed: 26147473
Trans R Soc Trop Med Hyg. 1991 Sep-Oct;85(5):667-9
pubmed: 1781004
PLoS One. 2017 Jun 22;12(6):e0178855
pubmed: 28640820
Am J Epidemiol. 1985 Nov;122(5):904-14
pubmed: 4050778
Vaccine. 2013 Dec 16;31(52):6170-1
pubmed: 23746456
Infect Genet Evol. 2019 Apr;69:68-75
pubmed: 30641151
J Trop Pediatr. 2018 Apr 1;64(2):141-145
pubmed: 28582541
Clin Infect Dis. 2016 May 1;62 Suppl 2:S96-S105
pubmed: 27059362
Int J Infect Dis. 2011 Sep;15(9):e646-52
pubmed: 21763172
Vet Microbiol. 2010 Dec 15;146(3-4):253-9
pubmed: 20605380
BMC Public Health. 2009 Feb 24;9:67
pubmed: 19236726
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
Lancet. 2016 Sep 24;388(10051):1291-301
pubmed: 27673470
J Clin Microbiol. 1990 Feb;28(2):276-82
pubmed: 2155916
Lancet. 2015 Dec 5;386(10010):2275-86
pubmed: 26361942
J Gen Virol. 2019 Jun;100(6):932-937
pubmed: 31140967
PLoS One. 2015 May 14;10(5):e0119824
pubmed: 25973880
Bull World Health Organ. 2001;79(6):546-52
pubmed: 11436477